NCT05195047View on ClinicalTrials.gov

Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 2)

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 27, 2022

Primary Completion Date

August 21, 2022

Study Completion Date

August 21, 2022

Conditions
SARS-CoV-2
Interventions
DIETARY_SUPPLEMENT

1 week placebo(Week 1)

1 week of consecutively consuming oral placebo (1 time/day)

DIETARY_SUPPLEMENT

1 week of probiotics(Week 1)

1 week of consecutively consuming oral probiotics (1 time/day)

DIETARY_SUPPLEMENT

1 week placebo(Week 2)

1 week of consecutively consuming oral placebo (1 time/day)

DIETARY_SUPPLEMENT

1 week of probiotics(Week 2)

1 week of consecutively consuming oral probiotics (1 time/day)

DIETARY_SUPPLEMENT

1 week placebo(Week 3)

1 week of consecutively consuming oral placebo (1 time/day)

DIETARY_SUPPLEMENT

1 week of probiotics(Week 3)

1 week of consecutively consuming oral probiotics (1 time/day)

Trial Locations (2)

Unknown

Beijing Pinggu Hospital, Beijing

Peking University Health Science Center Hospital, Beijing

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention, China

OTHER_GOV

collaborator

Beijing Pinggu District Hospital

OTHER

collaborator

Peking University Health Science Center Hospital

UNKNOWN

lead

Peking University

OTHER